Physician profile
Victor Wang
NPI 1518225952
$7,676.59
in general payments reported to CMS, 2019-2025
12 companies · $6,176 in 2025
The $6,176 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.31 · 2021: $110 · 2022: $209 · 2023: $522 · 2024: $646 · 2025: $6,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,148 · Consulting Fee: $2,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Travel and Lodging: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,148.06 |
| Consulting Fee | $2,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Travel and Lodging | $1,396.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,123.22 | 2023-2025 | |
| Tris Pharma INC | $2,000.00 | 2025 | |
| Ipsen Innovation | $1,670.20 | 2025 | |
| Abbvie INC. | $908.21 | 2023-2025 | Ubrelvy, Qulipta |
| Lundbeck LLC | $590.13 | 2023-2025 | Vyepti |
| Medtronic, INC. | $286.75 | 2021-2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $46.83 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $20.12 | 2025 | Ajovy |
| Lilly USA, LLC | $17.82 | 2023 | Emgality, Reyvow |
| Medtronic USA, INC. | $13.31 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.